Multispecialty Hospital Tie-ups & Inpatient Critical Care

While PCRI delivers outpatient chemotherapy, targeted therapy, and supportive care in its dedicated day care suites, certain complex oncological scenarios — such as high-risk surgical resections, neutropenic sepsis, severe electrolyte disturbances, and acute organ compromise — require immediate inpatient tertiary hospital infrastructure and Intensive Care Unit (ICU) support.

To provide complete safety and seamless continuity of care, PCRI's senior medical oncologists — Dr. Anshul Agrawal and Dr. Dhruv Mehta — hold prestigious Visiting Faculty and Honorary Consultant positions across the leading tertiary and trust hospitals in Surat.

Affiliated Hospital Network in Surat

Through our formalized hospital affiliations, PCRI patients enjoy direct, prioritized admission privileges at:

• Mahavir Cancer Hospital: Dedicated oncology hospital with comprehensive surgical suites and radiotherapy facilities.
• Shalby Multi-Specialty Hospital: Advanced multi-organ surgical infrastructure, high-end ICU, and 24/7 emergency critical care.
• Omega Cancer Hospital: Specialized tertiary oncological inpatient suites and emergency oncology wings.
• Lions Cancer Detection Center: Renowned diagnostic and therapeutic oncology facility with extensive patient trust and outreach.
• Yashfeen Hospital: High-capacity multispecialty inpatient care and surgical amenities.
• Universal Hospital: State-of-the-art critical care facilities and emergency response services.

Key Clinical Advantages for PCRI Patients

• 24/7 Rapid Emergency Admissions: Zero delays or paperwork bottlenecks when a patient experiences acute oncological emergencies like febrile neutropenia, acute bleeding, or respiratory distress.
• Total Continuity of Treatment: Patients admitted to these partner hospitals are directly treated and monitored by their own PCRI oncologist, maintaining consistent therapeutic plans without disruptive handoffs.
• Multidisciplinary Surgical & ICU Coordination: Seamless coordination with experienced oncosurgeons, neurosurgeons, thoracic surgeons, and intensivist teams for complex combined-modality interventions.

Gallery